Digital Pathology
According to Data Bridge Market Research new Market report, “Global Digital Pathology Market By Product (Scanners, Software, Communication Systems, Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education), By End Users (Pharmaceutical & Biotechnology Companies, Hospital and Reference Laboratories and Academic & Research Institutes), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to …
Pune, Sept. 09, 2020 (GLOBE NEWSWIRE) – The global digital pathology market is likely to expand due to the rising use of advanced diagnostic tools for prompt diagnosis of chronic diseases. According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases. Furthermore, the global digital pathology market is likely to …
… to capture vital encounter-based images and videos easily as well as documents and integrate them with a PACS or EMR. “Hyland is currently investing in and working with international partners to develop a digital pathology solution that incorporates its zero-footprint NilRead enterprise and diagnostic viewer and Acuo VNA. Anticipating the future, it also designed its products to be cloud-based,” noted Dr. Kuppuswamy. “As a result of its …
DoD taps Google Cloud for digital pathology pilot - MedCity News | 9/8/2020
DoD taps Google Cloud for digital pathology pilot - MedCity News Augmented/Views …
TOPICS: Clinical Solutions Digital Pathology September 8, 2020 Oxford University Hospitals (OUH) NHS Foundation Trust has become one of the earliest UK adopters of a fully digitised cellular pathology (histopathology) department. OUH is one of the first NHS trusts in the country to achieve the status of digitising all surgical histology and referral slides within the cellular pathology department. OUH has worked with Philips to introduce their IntelliSite Pathology Solution …
Digital Pathology Industry Future of Pathology | 9/8/2020
Home Articles Digital Pathology Industry Future of Pathology Digital Pathology Industry Future of Pathology September 8, 2020 103 Views Digital Pathology Industry Future of Pathology Digital pathology involves converting glass slides into digital slides that can be observed, managed, shared, and examined on a computer monitor. With the influx of whole-slide imaging, the framework of digital pathology saw huge growth and is currently regarded as one of the most …
SGH, Philips to establish digital pathology CoE in Singapore | 9/6/2020
… and enhance patient care. Located within SGH’s Division of Pathology, one of the largest pathology laboratories in ASEAN, the Center of Excellence aims to establish ASEAN’s first fully digitized histopathology laboratory by expanding its digital pathology capabilities for primary diagnosis, training, and R&D with the Philips IntelliSite Pathology Solution . Both SGH and Philips will also work closely on other diverse areas, including streamlining of the histopathology laboratory’s digital workflow …
Google Cloud is working with the US Department of Defense (DoD) to deliver an augmented reality (AR) microscope for cancer diagnoses. The project, for the Defense Innovation Unit (DIU), more widely involves prototyping an AI-enabled digital pathology solution at select DoD facilities. The company cited research from the Veterans Affairs Center for Innovations in Quality, Effectiveness and Safety which found up to 5% of outpatient diagnoses were conducted in …
Contact September 04, 2020 Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems BY James Clinical Laboratories , Clinical Pathology , Device Manufacturers , Digital Pathology News , FDA Approval , Image Analysis , International , Laboratory Management & Operations , New Digital Imaging Technologies , Pathology News , Vendor products MEDIA RELEASE First commercial test for fully automated high throughput systems to detect and differentiate SARS …
US Military Health System taps Google Cloud to prototype AI predictive cancer diagnostic tool Jackie Drees - Print Email The Defense Innovation Unit selected Google Cloud to develop a prototype for an artificial intelligence-enabled digital pathology tool that will help Military Health System physicians with cancer detection tasks. The project aims to improve the accuracy of cancer and other disease diagnoses as well as help physicians manage large volumes of …
US Defense Department Selects Google Cloud to Develop Digital Pathology Tool - 360Dx | 9/3/2020
US Defense Department Selects Google Cloud to Develop Digital Pathology Tool - 360Dx Augmented/Views …
… of £50 million for the development of artificial intelligence technology within diagnostic centres of excellence, to help speed up diagnosis of conditions including cancer. The funding boost will scale up the work of existing Digital Pathology and Imaging Artificial Intelligence Centres of Excellence, which were launched in 2018 to develop cutting-edge digital tools to improve the diagnosis of diseases across the NHS. The three centres set to receive a …
… strategies such as acquisition, business expansion and novel product launches to consolidate their market presence. For instance, in June 2020 , Roche announced the CE-IVD launch of its uPath PD-L1 (SP263), an automated digital pathology algorithm. The uPath PD-L1 (SP263) is used for image analysis for non-small cell lung cancer (NSCLC). This strategy is expected to help the company add value to their business portfolio as well …
Digital Pathology Market Companies, Business Overview and Forecast to 2023 | 9/3/2020
by Shrikant Gadewar on 11 minutes ago 5 views MRFR has been Recording a Fidel Report on “Digital Pathology Market-Global Forecast to 2023” Market Synopsis Market Research Future (MRFR) asserts that the global digital pathology market is estimated to expand radiantly during the forecast period (2017-2023) owing to the augmenting number of pathologists. Digital pathology is referred to as an active, image-based setting that allows the management, procurement …
Microtome Market worth $177 million by 2024 | 9/3/2020
… Laboratories) – Global Forecast to 2024″ , is expected to grow from USD 129 million in 2019 to reach USD 177 million by 2024, at a CAGR of 6.5%. High prevalence of cancer, growing demand for digital pathology , and increasing healthcare expenditure are the major factors driving the growth of this market. Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411 Manual microtomes accounted for the largest share of the microtomes market, by …
Share Using AI and Augmented Reality, Google Cloud Will Help Improve Patient Outcomes and Reduce Cost Google Cloud announced that the Defense Innovation Unit (DIU) has chosen Google Cloud to prototype an AI-enabled digital pathology solution at select DoD facilities. The project includes the delivery of augmented reality microscopes to DoD’s medical facilities and access to artificial intelligence (AI) models that can help military doctors with cancer detection tasks …
First U.S. Lab Implements AI-based Solution for Cancer Detection in Pathology | 9/3/2020
First U.S. Lab Implements AI-based Solution for Cancer Detection in Pathology BY James Artificial Intelligence , Clinical Laboratories , Current Affairs , Data Management , Device Manufacturers , Digital Pathology News , File format , Image Analysis , Informatics , Laboratory Informatics , Laboratory Information Systems , Laboratory Management & Operations , New Digital Imaging Technologies , Pathology News , Vendor products , Whole slide CorePlus completes deployment of Ibex Medical Analytics’ Galen™ Prostate solution to support pathologists in accurate diagnosis, enhanced lab efficiency and …
… intelligence-based software developed by Israeli startup Ibex Medical Analytics to detect prostate cancer. CorePlus Servicios Clínicos y Patológicos, LLC, a clinical and anatomic pathology laboratory, on Tuesday announced the first deployment of the digital pathology solution at its main facilities in Carolina, a municipality located on the northeast coast of Puerto Rico. The technology will become CorePlus’s new standard of care for the diagnosis and treatment of prostate cancer …
Digital pathology dispels the microscope | 9/2/2020
… make diagnoses outside the physical boundaries of their (own) department and quickly consult each other when an additional opinion is needed. This allows laboratories to work on increasing the efficiency of diagnostics. Transition to digital pathology More and more pathology departments now have access to digital scanners. However, there are still very few who already work completely digitally. This requires, among other things, a change in the mindset of pathologists …
U.K. increases funding for AI to diagnose disease | 9/2/2020
U.K. increases funding for AI to diagnose disease By AuntMinnieEurope.com staff writers September 2, 2020 – The U.K. government said that it’s investing an additional 50 million pounds (56.2 million euros) to scale up the efforts of its existing digital pathology and imaging artificial intelligence (AI) centers of excellence. The centers of excellence were launched in 2018 with the goal of using AI to improve the diagnosis of disease. Three centers …
DIU Selects Google Cloud to Develop AI Technology for DoD; Mike Daniels Quoted | 9/2/2020
… Daniels Quoted Sarah Sybert September 2, 2020 News , Press Releases , Technology Mike Daniels VP Public Sector Google Cloud Google Cloud has been selected by the Defense Innovation Unit (DIU) to prototype an AI-enabled digital pathology solution at Department of Defense (DoD) facilities, including the delivery of augmented reality microscopes to DoD’s medical facilities and access to artificial intelligence (AI) models, the company reported on Monday. “To effectively treat cancer …
Visiopharm raises fresh capital with BankInvest as lead investor | PR Newswire | 9/1/2020
… programs in geographies beyond Europe , including in the US.” With an install base of 75+ diagnostic pathology labs in Northern Europe , Visiopharm is already one of the largest diagnostic players in the European diagnostic digital pathology market. These installations are still in a relatively narrow geography, as Visiopharm only started accelerating its geographic expansion beyond Scandinavia as recent as in 2018, following a significant investment with ATP as the lead …
£50 Million Funding for Artificial Intelligence in NHS | 9/1/2020
50 Million Funding for Artificial Intelligence in NHS Tuesday, 1 September 2020, 8:54 £50 Million Funding for Artificial Intelligence in NHS A £50 million funding boost will scale up the work of existing Digital Pathology and Imaging Artificial Intelligence Centres of Excellence, which were launched in 2018 to develop cutting-edge digital tools to improve the diagnosis of disease. Funding boost for artificial intelligence in NHS to speed up diagnosis …
… pathway involved in the regulation of tumor metabolism. We investigated whether certain metabolism-related in situ biomarkers could predict benefit to regorafenib in the phase II randomized REGOMA trial. Patients and Methods: IHC and digital pathology analysis were used to investigate the expression in glioblastoma (GBM) sections of monocarboxylate transporter 1 and 4 (MCT1 and MCT4), associated with OXPHOS and glycolysis, respectively, phosphorylated AMPK (pAMPK), and phosphorylated acetyl-CoA carboxylase …
NHS to Receive £50 Million in Funding to Boost AI Usage | 9/1/2020
… million funding boost to develop the use of artificial intelligence (AI) in the diagnosis and treatment of serious diseases like cancer. The investment will go to scaling up work at the NHS’s three existing Digital Pathology and Imaging Artificial Intelligence Centres of Excellence. These were launched in 2018 to develop cutting-edge digital tools to improve the diagnosis of disease. Each of the three centres, based in Coventry, Leeds and …
Laboratory Information Systems
Motic Digital Pathology launches telepathology program globally | Healthcare IT News | 8/19/2020
… whole slide images and is cross-compatible with most other WSIs, the company says. August 19, 2020 03:03 PM Motic Digital Pathology this week announced the global launch of its telepathology program, which allows pathologists … vendor, and can automate case-information entry using hospital and laboratory information systems. Since 2018, the American Society for Clinical Pathology’s Partners for Cancer Diagnosis and Treatment Initiative has used MoticFlow to connect hospitals, primarily …
COVID-19
… BUSINESS WIRE)–Jun 29, 2020– Diagnostic laboratories continue to be a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic. XIFIN CEO Lâle White and … revenue cycle management, laboratory information systems, precision medicine informatics and digital pathology consultation services. Its cloud-based platform offers real-time connectivity, workflow automation, data exchange and actionable insights, linking healthcare stakeholders in the delivery …
National Cancer Institute
… has clear implications for clinical care. Findings from the study were published June 25, 2020, in the Journal of the National Cancer Institute . The algorithm was developed and the study conducted by investigators at the … that their findings serve as an important example for introducing digital pathology and deep learning into clinical practice, and their approach has the potential to substantially improve cervical cancer screening, affecting millions of women testing …
HIPAA
The “North American Digital Pathology Market 2019-2025” report has been added to ResearchAndMarkets.com ‘s offering. The North American digital pathology market is growing at a CAGR of approximately 14.3% during the forecast period. There are … implementing this technology. The Health Insurance Portability and Accountability Act (HIPAA) imposes a number of security and privacy requirements on digital pathology systems in the US. This act is focused on the concept of Protected …
NIH
… and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased to announce the online COVID Digital Pathology Repository (COVID-DPR) , a virtual collection of high resolution microscopic COVID-related human … entire Indica Labs team takes great pride in working with NIH and Octo to deliver a much-needed global integration for COVID-19 pathology and a framework for the implementation of further cutting-edge technologies …
Enterprise Imaging
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … identified in this market include, among others, 3DHISTECH Ltd. Apollo Enterprise Imaging Corp. Carl Zeiss AG Corista LLC Definiens AG Hamamatsu Photonics K.K. Huron Digital Pathology Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc. Olympus …
Companion Diagnostics
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … Personalized Medicine Bodes Well for Digital Pathology Increased Focus on Companion Diagnostics to Benefit the Market Digital Pathology Images and the Quality Concerns Improving Healthcare & Research Expenditures Turbo Charge Digital Pathology Burgeoning Global Population: A …
Food and Drug Administration
… today announced the appointment of Dr. Yun-Fu Hu as Chief Medical Officer. A former deputy director with the US Food and Drug Administration (FDA), Dr. Hu will be tasked to steer the company forward … LDTs) for genetic testing, molecular cancer diagnostics, companion diagnostics, radiodosimetry, digital pathology and artificial intelligence devices. Some of his notable authorizations include: the first next generation sequencing (NGS)-based LDT as companion diagnostics (CDx) (Foundation …
PACS
… International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic … navigate and zoom the whole slide images. HSS installed Sectra PACS for radiology in 2010 and added its specialty orthopedic modules in 2018. “We are excited to see the benefits HSS will experience by incorporating …
Health Research
… Health Research (NIHR) Oxford Biomedical Research Centre (BRC). Disclaimer The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health. CV, RC, LB and JR are part of the PathLAKE digital pathology consortium (JR and CV are PIs). These new Centres are supported by a £50m investment from the Data to Early Diagnosis and Precision Medicine …
Clinical Research
Partners Pursue FDA Clearance for Integrated Digital Pathology Solution | 1/15/2020
Partners Pursue FDA Clearance for Integrated Digital Pathology Solution 14, 2020 Sectra, Linköping, Sweden, and Leica Biosystems, Shelton, Conn, have collaborated to develop an integrated digital pathology solution that will address the needs of enterprise-level clinical customers such as academic medical centers, clinical research organizations, and large hospital networks. A premarket notification (510(k)) application for the combined solution has been submitted to FDA. “Leveraging Leica Biosystems’ existing 510 …
Telehealth
2019 closes the year with 251 digital health fundings | MobiHealthNews | 12/31/2019
… as well as push into other international markets. Additionally, it will use funds for product development and to promote its telehealth offering, which just launched last month. Doctolib offers its subscription-based SaaS platform to … Brazilian and Canadian markets. The AI company uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at a lower cost. Q4 Northpond Ventures, Section 32, Founders Fund, Sands …
Precision Medicine
… co-founder of Invicro, will move on from his role as Invicro’s CEO to be the President of Konica Minolta Precision Medicine (KMPM). Dr. Hoppin will remain on Invicro’s Board of Directors, as well as … through the delivery of diagnostic services via genetics, imaging and digital pathology capabilities. Konica Minolta Precision Medicine was formalized as a result of bringing these three entities together. “It has been an extreme honor to …
Medical Imaging
Sectra and Leica Biosystems partner to pursue FDA clearance for an integrated clinical digital pathology solution Mon, Dec 02, 2019 09:00 CET Linköping, Sweden and Shelton, CT – December 2, 2019 – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) and Leica Biosystems announce collaboration for an integrated clinical pathology solution. The goal is to address the clinical needs of enterprise level customers such as academic medical centers, clinical …
Cancer Diagnostics
Sectra and Leica Biosystems Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology Solution News provided by Sectra, Inc Dec 02, 2019, 11:00 ET SHELTON, Connecticut , Dec. 2, 2019 /PRNewswire/ – International medical imaging … www.sectra.com/medical/ . About Leica Biosystems Leica Biosystems ( LeicaBiosystems.com ) is a cancer diagnostics company and a global leader in workflow solutions, offering the most comprehensive portfolio from biopsy to diagnosis. With unique expertise, Leica Biosystems is …
EMR
Sectra and Leica Biosystems Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology Solution News provided by Sectra, Inc Dec 02, 2019, 11:00 ET SHELTON, Connecticut , Dec. 2, 2019 /PRNewswire/ – International medical imaging … well as deep integration with leading pathology information systems and EMRs. Leica Biosystems Aperio AT2 DX system is a high-throughput automated digital scanner that delivers diagnostic-quality whole slide images with high confidence. The …
Health Management
Global Healthcare Information Technology (HCIT) Market Size was at USD 125 Billion in 2015, and is Estimated to Reach USD 297 Billion by 2022, With a CAGR of 13.2% - Valuates Reports™ News provided by Nov 28, 2019, 08:15 ET BANGALORE, India , Nov. 28, 2019 /PRNewswire/ – Global Healthcare IT Market Overview : 2022 The global healthcare IT market size was valued at USD 125 billion in 2015, reaching USD 297 billion by …
Diagnostic Imaging
Medical Display Market - New Technologies Transforming the Industrial Business | 11/28/2019
… Technologies Transforming the Industrial Business Technology (LED, OLED) Panel Size (≤22.9”, 27.0-41.9”, ≥42”) Resolution (≤2MP, 4.1-8MP, ≥8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display Color ( EMAILWIRE.COM , November 28, 2019 ) “ Medical Display Market by … preference for minimally invasive treatments, and the rising number of diagnostic imaging centers are the major factors driving the growth of the market.LED-backlit LCD displays held the largest share of the medical display market …
Revenue Cycle Management
Global Healthcare Information Technology (HCIT) Market Size was at USD 125 Billion in 2015, and is Estimated to Reach USD 297 Billion by 2022, With a CAGR of 13.2% - Valuates Reports™ News provided by Nov 28, 2019, 08:15 ET BANGALORE, India , Nov. 28, 2019 /PRNewswire/ – Global Healthcare IT Market Overview : 2022 The global healthcare IT market size was valued at USD 125 billion in 2015, reaching USD 297 billion by …
Medical Research
Cleveland-based startup will use federal grant to develop AI tools for TB detection | 11/27/2019
Cleveland–Diascopic LLC, a Cleveland-based medical research company that develops diagnostic technology, will use a highly competitive federal grant to develop and apply new artificial intelligence (AI) and digital pathology tools for detecting tuberculosis (TB). Company principals Cary Serif, chief executive officer, and Jim Uhlir, vice president of research and engineering, are focused on rapid, mobile, low-cost and accurate digital pathology solutions for pressing health problems. According to …
Clinical Data
… digital pathology, and A STAR’s Institute of Molecular and Cell Biology (IMCB) have launched a joint digital immuno-oncology laboratory. Located at IMCB, the new IMCB-A!maginostic Joint Lab of Excellence aims to provide artificial intelligence (AI) and machine learning (ML) solutions to support computational digital and multiplex pathology, by integrating multi-modality images and clinical data, including patient treatment and survival status. Image Caption: A prostate cancer patient …
Biotech
… cancer diagnostic assays SINGAPORE, 25 NOVEMBER 2019 – A!maginostic (A!), an A STAR spin-off 1 that specialises in computational digital pathology, and A STAR’s Institute of Molecular and Cell Biology (IMCB) have launched a … medical and research communities, and will be open to partner biotech companies to develop new capabilities in digital pathology. The lab will build a cloud-based large-scale pathology database of annotated cancer tissue images …
Genomics
… Agilent Technologies Inc. Agilent Technologies Inc. operates the business across segments such as Life sciences and applied markets, Diagnostics and genomics, and Agilent CrossLab. Dako Autostainer Plus is one of the key offerings of the … as Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. Aperio Digital Pathology Slide Scanner is one of the key offerings of the company. F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. operates the …
AI in Healthcare
… AI in healthcare market in India. Early detection and management is a crucial strep for optimum cancer treatment. Digital pathology is a new concept introduced by AI that involves high resolution magnification of glass slides to provide accurate and precise annotation of all the images that are scanned. AI based Radionics aids in tumor phenotypes quantification using various imaging features. These advancements in medical sector boost AI market in India …
Diagnostic Tests
… Scientific (Australia), RMC Boeckeler, Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance (China). High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the … accessibility to advanced technologies, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving …
XIFIN
… a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic. XIFIN CEO Lâle White and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services … revenue cycle management, laboratory information systems, precision medicine informatics and digital pathology consultation services. Its cloud-based platform offers real-time connectivity, workflow automation, data exchange and actionable insights, linking healthcare stakeholders in the delivery …
Sectra
Swedish Healthcare Region to Realize Integrated Diagnostics - Expands IT Solution From Sectra With Digital Pathology News provided by Jun 29, 2020, 02:52 ET Share this article LINKÖPING, Sweden , June 29, 2020 /PRNewswire/ – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a digital pathology contract with Region Västmanland in Sweden . The healthcare region already uses Sectra’s software for handling medical images, which will now be expanded …
Roche Diagnostics
Roche has launched a new version of its digital pathology platform in Europe, with a CE-IVD mark for an artificial-intelligence-powered image analysis algorithm aimed at non-small cell lung cancer. The uPath … accurate diagnoses to cancer patients,” said Thomas Schinecker, CEO of Roche Diagnostics. “Our uPath PD-L1 (SP263) image analysis for non-small cell lung cancer is the first next-generation CE-IVD PD-L1 algorithm …
Proscia
Digitizing And Automating Unsung Heroics: The Case Of Pathology | Forbes | 6/23/2020
… under a microscope. Most pathologists continue to work in microscope-equipped labs, rather than in front of computer screens. But “digital pathology,” in which pathologists examine digital images rather than slides, is on the rise … on patient therapy and decision-making at relatively low cost. Proscia, Digital Pathology, and AI Proscia , a company founded in 2014 and based in Philadelphia, originally developed a digital pathology platform called Concentriq. It uses …
Quest Diagnostics
Digitizing And Automating Unsung Heroics: The Case Of Pathology | Forbes | 6/23/2020
… under a microscope. Most pathologists continue to work in microscope-equipped labs, rather than in front of computer screens. But “digital pathology,” in which pathologists examine digital images rather than slides, is on the rise … be good for the profession. According to one study by Quest Diagnostics , lab results account for 70% of decisions about inpatient care, but only 3-4% of budgets. Changes in pathology lab processes, then, could have …
Corista
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … others, 3DHISTECH Ltd. Apollo Enterprise Imaging Corp. Carl Zeiss AG Corista LLC Definiens AG Hamamatsu Photonics K.K. Huron Digital Pathology Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc. Olympus Corporation Philips Healthcare Pixcelldata Ltd. Ventana …
Philips Healthcare
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc. Olympus Corporation Philips Healthcare Pixcelldata Ltd. Ventana Medical Systems Inc. VMscope GmbH. Read the full report: https://www.reportlinker.com/p05205340/?utm_source=PRN I. INTRODUCTION, METHODOLOGY & REPORT SCOPE …
Apollo Enterprise Imaging
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … Competitors identified in this market include, among others, 3DHISTECH Ltd. Apollo Enterprise Imaging Corp. Carl Zeiss AG Corista LLC Definiens AG Hamamatsu Photonics K.K. Huron Digital Pathology Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc …
Leica Biosystems
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … LLC Definiens AG Hamamatsu Photonics K.K. Huron Digital Pathology Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc. Olympus Corporation Philips Healthcare Pixcelldata Ltd. Ventana Medical Systems Inc. VMscope GmbH. Read the full report: https://www.reportlinker.com …
GE Healthcare
… GE Healthcare, Johnson & Johnson, Qiagen, and Siemens Healthcare. On the basis of Product, the Global Tissue Diagnostic Market is studied across Accessories and Instruments.On the basis of Technology, the Global Tissue Diagnostic Market is studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.On the basis of Application , the Global Tissue Diagnostic Market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and …
Siemens
… Siemens Healthcare. On the basis of Product, the Global Tissue Diagnostic Market is studied across Accessories and Instruments.On the basis of Technology, the Global Tissue Diagnostic Market is studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.On the basis of Application , the Global Tissue Diagnostic Market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.On the basis of End …
Qiagen
… Qiagen, and Siemens Healthcare. On the basis of Product, the Global Tissue Diagnostic Market is studied across Accessories and Instruments.On the basis of Technology, the Global Tissue Diagnostic Market is studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.On the basis of Application , the Global Tissue Diagnostic Market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.On the basis …
Siemens Healthcare
… Siemens Healthcare. On the basis of Product, the Global Tissue Diagnostic Market is studied across Accessories and Instruments.On the basis of Technology, the Global Tissue Diagnostic Market is studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.On the basis of Application , the Global Tissue Diagnostic Market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.On the basis of End …
Epic Systems
… International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic … read more here Epic and Beaker are registered trademarks of Epic Systems Corporation. About Sectra Imaging IT Solutions With more than 30 years of innovation and approaching 2,000 installations worldwide, Sectra is a leading global …
Cerner
The telehealth market is projected to grow at a CAGR of 16.9% | Globe Newswire | 4/6/2020
… Ireland), GE Healthcare (US) are the leading players in the global telehealth market. Other notable players in this market include Cerner Corporation (US), Siemens Healthineers (Germany), Cisco Systems, Inc. (US), Teladoc Health Inc. (US), American … on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end-user, and region. • Product Development/Innovation: Detailed insights on upcoming …
Sectra AB
… am pleased to present CEO Torbjörn Kronander. (Operator Instructions) I’ll now hand the floor to Torbjörn. Please begin. Torbjörn Kronander, Sectra AB (publ) - President, CEO & Director [2] All right. And good morning. This is Torbjörn … radiology PACS, but now they want cardiology and they want digital pathology in the same system. We are the only vendor who have all of these in the same system. And so we have new …
Aiforia
Aiforia enters the clinic with CE-IVD marked product and €2.1M EU Horizon 2020 grant | 1/7/2020
An intuitive, versatile platform optimized for the clinical pathology workflow 1.0.0.20 HELSINKI, Finland , Nov. 18, 2019 /PRNewswire/ — Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.1 million in funding from the EU’s Horizon 2020 program. The EU grant was awarded to support Aiforia’s ongoing development work of its artificial intelligence (AI) solutions for digital pathology with the …
Sunquest
December 2019 Product Focus – LIS | 11/25/2019
… Sunquest CoPathPlus LIS offers a highly customizable, task-based user experience aimed at the most complex Anatomic Pathology (AP) lab operations, while monitoring cost and resource savings, interoperability and improved outcomes. It has a targeted focus on AP/CP integration to help drive greater workflow efficiency across disciplines, improve TAT and influence patient outcomes, resulting in increased automation, digital pathology integration, molecular and genetics testing and more. Sunquest Information Systems …
Bristol-Myers
PathAI Gets $75m For Their AI Pathology Algorithms | 11/18/2019
… has closed a Series B financing round after snagging $15 million from Merck Global Health Initiative Fund (Merck GHIF) and Bristol-Myers Squibb. This brings the total amount of money raised in this financing round … that PathAI’s industry-leading work of incorporating artificial intelligence into digital pathology holds the potential to change the way cancer is treated and diagnosed. Global Head of Translational Medicine at Bristol-Myers Squibb, Saurabh Saha …
Merck
PathAI Gets $75m For Their AI Pathology Algorithms | 11/18/2019
… artificial intelligence-powered technology for advancing pathology research, has closed a Series B financing round after snagging $15 million from Merck Global Health Initiative Fund (Merck GHIF) and Bristol-Myers Squibb. This brings the total … that PathAI’s industry-leading work of incorporating artificial intelligence into digital pathology holds the potential to change the way cancer is treated and diagnosed. Global Head of Translational Medicine at Bristol-Myers Squibb, Saurabh Saha …
Bristol-Myers Squibb
PathAI Gets $75m For Their AI Pathology Algorithms | 11/18/2019
… has closed a Series B financing round after snagging $15 million from Merck Global Health Initiative Fund (Merck GHIF) and Bristol-Myers Squibb. This brings the total amount of money raised in this financing round … that PathAI’s industry-leading work of incorporating artificial intelligence into digital pathology holds the potential to change the way cancer is treated and diagnosed. Global Head of Translational Medicine at Bristol-Myers Squibb, Saurabh Saha …
PathAI
PathAI Gets $75m For Their AI Pathology Algorithms | 11/18/2019
PathAI, a company that uses artificial intelligence-powered technology for advancing pathology research, has closed a Series B financing round after snagging $15 million from Merck Global Health Initiative Fund (Merck GHIF) and Bristol-Myers … that PathAI’s industry-leading work of incorporating artificial intelligence into digital pathology holds the potential to change the way cancer is treated and diagnosed. Global Head of Translational Medicine at Bristol-Myers Squibb, Saurabh Saha …
Thermo Fisher
… Thermo Fisher Scientific (US), Danaher Corporation (US), and Sakura Finetek (Japan) dominated the microtomes market. Other prominent players in this market include SLEE Medical GmbH (Germany), MEDITE GmbH (Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia), RMC Boeckeler, Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance (China). High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes …
Thermo Fisher Scientific
… Thermo Fisher Scientific (US), Danaher Corporation (US), and Sakura Finetek (Japan) dominated the microtomes market. Other prominent players in this market include SLEE Medical GmbH (Germany), MEDITE GmbH (Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia), RMC Boeckeler, Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance (China). High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes …
HistoIndex
SINGAPORE , Nov. 11, 2019 /PRNewswire/ – qFIBS, a novel automated algorithm developed by HistoIndex, has been shown to accurately distinguish different grades and stages of histological NASH features with a continuous measurement approach. This was highlighted … tools for NAFLD, especially for NASH 4 . Having a precise digital pathology tool with AI-based imaging and analytical capabilities will help us derive a clearer assessment of liver biopsies, as well as provide significant …
Breyer Capital
2019 closes the year with 251 digital health fundings | MobiHealthNews | 12/31/2019
… Breyer Capital, Kenan Turnacioglu and other funders The company said the new cash will be put towards getting FDA clearance for its products and further development. The company is also looking to build up its commercialization in the US as well as expand to the European, Brazilian and Canadian markets. The AI company uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at …
Paige Raises $45 Million to Accelerate the Future of Pathology | 12/30/2019
… Million to Accelerate the Future of Pathology BY James Artificial Intelligence , Business , Clinical Laboratories , Clinical Pathology , Data Management , Device Manufacturers , Digital Pathology News , File format , Image Analysis , Informatics , International , Laboratory Informatics , New Digital Imaging Technologies … Venture Partners brought the largest contribution to the round, with Breyer Capital, Kenan Turnacioglu, and other funds participating. Paige will use this new capital to drive FDA clearance of its products and expand its portfolio …
General Atlantic
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new digital tools and medical devices for the diagnosis of diseases like cancer. Merck and BMS join investors including LabCorp, General Catalyst and General Atlantic, which led the overall round …
… Squibb to complete $75M Series B Funding Share Article Backing by leading immuno-oncology companies underscores the broad potential for digital pathology and strength of PathAI. BOSTON PathAI, a global leader in artificial intelligence-powered … announced in April , which was led by venture capital firms General Atlantic and General Catalyst, with strategic participation from LabCorp, a leading global life sciences company that provides comprehensive clinical laboratory and end-to-end …
General Catalyst
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new digital tools and medical devices for the diagnosis of diseases like cancer. Merck and BMS join investors including LabCorp, General Catalyst and General Atlantic, which led the overall round …
… Squibb to complete $75M Series B Funding Share Article Backing by leading immuno-oncology companies underscores the broad potential for digital pathology and strength of PathAI. BOSTON PathAI, a global leader in artificial intelligence-powered … which was led by venture capital firms General Atlantic and General Catalyst, with strategic participation from LabCorp, a leading global life sciences company that provides comprehensive clinical laboratory and end-to-end drug development service …
Innovation Fund
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new digital tools and medical devices for the diagnosis of diseases like cancer. Merck and BMS join investors including LabCorp, General Catalyst and General Atlantic, which led the overall round …
… for use in pathology research, closed its Series B investment round Nov. 4, including participation from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. The infusion from the two pharmaceutical giants brings PathAI’s … news release, “[PathAI’s] industry-leading work incorporating artificial intelligence into digital pathology holds the potential to change the way we diagnose and treat cancer.” More articles on AI …
Health Innovation Fund
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
Seven months after banking $60 million, PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new digital tools and medical devices for the diagnosis of diseases like cancer. Merck and BMS join investors including LabCorp, General Catalyst and General Atlantic, which led the overall round …
… technology for use in pathology research, closed its Series B investment round Nov. 4, including participation from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. The infusion from the two pharmaceutical giants brings … news release, “[PathAI’s] industry-leading work incorporating artificial intelligence into digital pathology holds the potential to change the way we diagnose and treat cancer.” More articles on AI …
Merck Global Health Innovation
… artificial intelligence technology for use in pathology research, closed its Series B investment round Nov. 4, including participation from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. The infusion from the two pharmaceutical … news release, “[PathAI’s] industry-leading work incorporating artificial intelligence into digital pathology holds the potential to change the way we diagnose and treat cancer.” More articles on AI …
Backing by leading immuno-oncology companies underscores the broad potential for digital pathology and strength of PathAI. BOSTON PathAI, a global leader in artificial intelligence-powered technology for advancing pathology research, announced today that it has secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Squibb. These investments complete PathAI’s Series B investment round. PathAI will use the funding to bolster and accelerate its …
Merck Global Health Innovation Fund
… artificial intelligence technology for use in pathology research, closed its Series B investment round Nov. 4, including participation from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. The infusion from the two pharmaceutical … news release, “[PathAI’s] industry-leading work incorporating artificial intelligence into digital pathology holds the potential to change the way we diagnose and treat cancer.” More articles on AI …
Backing by leading immuno-oncology companies underscores the broad potential for digital pathology and strength of PathAI. BOSTON PathAI, a global leader in artificial intelligence-powered technology for advancing pathology research, announced today that it has secured strategic investments from the Merck Global Health Innovation Fund (Merck GHIF) and Bristol-Myers Squibb. These investments complete PathAI’s Series B investment round. PathAI will use the funding to bolster and accelerate its …
Northpond Ventures
… translational and pathology research labs, today announced the close of a $22 Million Series C funding led by new investor Northpond Ventures and fueled by existing investors including ARCH Venture Partners, 6 Dimensions Capital, Yonghua … biomarker assays in tissue for research in personalized medicine and digital pathology. By developing a single set of novel, proprietary reagents used both for biomarker discovery (higher content, low throughput) and translational use (lower content …
Deep Lens raises $14 million to improve clinical trial recruitment with AI | VentureBeat | 4/8/2019
… startup developing a precision medicine software suite, today announced that it’s raised $14 million in series A funding led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners … validation of the value of our industry-changing approach to digital pathology in delivering the right cancer diagnoses faster and accelerating oncology trial recruitment and timelines.” “With this additional capital,” president and cofounder Simon Arkell …
Rev1 Ventures
Deep Lens raises $14 million to improve clinical trial recruitment with AI | VentureBeat | 4/8/2019
… today announced that it’s raised $14 million in series A funding led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. It brings the startup’s total raised to … validation of the value of our industry-changing approach to digital pathology in delivering the right cancer diagnoses faster and accelerating oncology trial recruitment and timelines.” “With this additional capital,” president and cofounder Simon Arkell …
Deep Lens collects another $13.7M for digital pathology | MobiHealthNews | 4/8/2019
Search Deep Lens collects another $13.7M for digital pathology The Series A round comes just half a year after the Columbus, Ohio-based startup’s prior fundraise. April 08, 2019 Share Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures …
Sierra Ventures
Deep Lens raises $14 million to improve clinical trial recruitment with AI | VentureBeat | 4/8/2019
… that it’s raised $14 million in series A funding led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. It brings the startup’s total raised to $17.5 million … validation of the value of our industry-changing approach to digital pathology in delivering the right cancer diagnoses faster and accelerating oncology trial recruitment and timelines.” “With this additional capital,” president and cofounder Simon Arkell …
Deep Lens collects another $13.7M for digital pathology | MobiHealthNews | 4/8/2019
… digital pathology The Series A round comes just half a year after the Columbus, Ohio-based startup’s prior fundraise. April 08, 2019 Share Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners, according …
Mayo Clinic
Mayo Clinic Launches Imaging Solution to Enable Digital Pathology Across the Enterprise News provided by Jun 25, 2020, 16:33 ET Share this article LINKÖPING, Sweden and SHELTON, Connecticut , June 25, 2020 /PRNewswire/ – In support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and …
Mayo Clinic Health System
Mayo Clinic Launches Imaging Solution to Enable Digital Pathology Across the Enterprise News provided by Jun 25, 2020, 16:33 ET Share this article LINKÖPING, Sweden and SHELTON, Connecticut , June 25, 2020 /PRNewswire/ – In support of … departments throughout Rochester, Florida , and Arizona , as well as the Mayo Clinic Health System. The new digital intake process will be piloted with a domestic Mayo Clinic Laboratories client later this year. “We are confident …
Hospital for Special Surgery
SHELTON, Connecticut , April 7, 2020 /PRNewswire/ – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health. This module—incorporated within the existing Sectra enterprise imaging solution and integrated with laboratory information system Epic Beaker—provides integrated diagnostics capabilities between …
Medical Center
Oesophagus Original research Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett’s dysplasia using digital pathology Myrtle J van der Wel 1 , Helen G Coleman 2 , on behalf of the BOLERO working group 1 Pathology , Amsterdam University Medical Center , Amsterdam , The Netherlands 2 Centre for Public Health , Queens University Belfast , Belfast , UK 3 Department of Gastroenterology , Academic Medical Center , Amsterdam , The …
University Hospital
… York / Tampa, Florida, March 27, 2020 (GLOBE NEWSWIRE) – SUNY Upstate has announced the acquisition and implementation of Dynamyx™ software from digital pathology and cancer informatics solution provider Inspirata. Fully integrating pathology systems and making them … and neurosurgical and pediatric services through its 715-bed Upstate University Hospital, which includes the Upstate Golisano Children’s Hospital. In addition to its clinical mission, Upstate enrolls 1,600 students and offers degrees. About Inspirata Inspirata …
SUNY Upstate Medical University
The State University of New York (SUNY) Upstate has implemented a fully integrated digital pathology solution from Inspirata. The Dynamyx™ Digital Pathology Workflow will enable deeper integration to meet SUNY Upstate’s strategic goals for delivering … solutions like Dynamyx,” said Satish Sanan, CEO of Inspirata. About SUNY Upstate Medical University The region’s largest employer with more than 10,000 employees, Upstate Medical University is the only academic medical center in Central New …
Memorial Sloan Kettering Cancer Center
… 17, 2020– As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic … institutions, including University of Florida, University of California, San Francisco, Memorial Sloan Kettering Cancer Center, and Granada University Hospitals New insights and best practices from digital pathology pioneers, including Zoltan Laszik, MD, PhD, Professor of …
John Hopkins Medicine
Digital Pathology Market: Opportunities and Challenges | 11/11/2019
RSS Digital Pathology Market: Opportunities and Challenges Growth in the overall market is mainly driven by factors such as the growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing … in countries in Asia-Pacific and Africa. According to a John Hopkins Medicine study, Malaysia and China have only 1 pathologist per 103,300 individuals and 1 pathologist per 74,000 individuals, respectively. Pathology Group of South …
Moffitt Cancer Center
… meeting and partnering with Inspirata’s founder, Dr. Mark Lloyd, a cancer researcher who at that time was working at the Moffitt Cancer Center. At that time, I knew very little about the process of cancer … therapeutic effectiveness. With the progress the industry has made with digital pathology, AI, NLP, and informatics, there’s reason to hope that, in five to 10 years, we will get to the point where data is …
Mount Sinai Health System
LabCorp, Philips and the Mount Sinai Health System are coming together to develop an artificial intelligence-driven pathology center of excellence, initially aimed at cancer diagnosis. The center will work to integrate digital pathology into clinical practices across Mount Sinai’s hospitals, starting with interpretations of prostate cancer and other genitourinary tumors, as well as cancers of the head and neck. From there, the project is slated to expand in scope …
Sinai Health System
LabCorp, Philips and the Mount Sinai Health System are coming together to develop an artificial intelligence-driven pathology center of excellence, initially aimed at cancer diagnosis. The center will work to integrate digital pathology into clinical practices across Mount Sinai’s hospitals, starting with interpretations of prostate cancer and other genitourinary tumors, as well as cancers of the head and neck. From there, the project is slated to expand in scope …
Inova Health System
FAIRFAX, Va. Inova Personalized Health Accelerator (IPHA) announced today an investment in Deciphex, a company developing digital pathology applications for clinical and toxicologic pathology. These applications triage high volume, low complexity samples, allowing pathologists to focus on the more difficult, critical content of pathology images. The Inova Personalized Health Accelerator (IPHA), a program that fosters med-tech innovation in technologies that are strategically important to the Inova Health System, recognizes …
Massachusetts General Hospital
Global Engage’s 4th Digital Pathology Congress: Europe will focus on understanding and utilizing digital pathology as a tool for advancing pathology practice and enabling enhanced patient care. The conference will take place in London on … Since 2001, Dr. Wilbur has led the Cytopathology Unit at Massachusetts General Hospital, where he is a practicing pathologist. In 2011, he took over the Pathology Department’s efforts in the emerging area of Clinical Imaging …
Thomas Schinecker
… cases Basel, June 26, 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung … higher-quality and more accurate diagnoses to cancer patients,” said Thomas Schinecker, CEO, Roche Diagnostics. “Our uPath PD-L1 (SP263) image analysis for non-small cell lung cancer is the first next-generation CE-IVD …
Carl Zeiss
Global Digital Pathology Systems Industry | PR Newswire | 4/20/2020
NEW YORK , April Digital Pathology Systems market worldwide is projected to grow by US$761.9 Billion , driven by a compounded growth of 11.5%. Device, one of the segments analyzed and sized in this study, displays … market include, among others, 3DHISTECH Ltd. Apollo Enterprise Imaging Corp. Carl Zeiss AG Corista LLC Definiens AG Hamamatsu Photonics K.K. Huron Digital Pathology Inc. Leica Biosystems Nussloch GmbH MikroScan Technologies Inc. Olympus Corporation Philips Healthcare …
Torbjörn Kronander
… International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has gone live with an initial phase of its digital pathology solution at New York’s Hospital for Special Surgery (HSS), the world’s leading academic … E-mail: [email protected] Phone: 203 925 0899 ext. 268 Torbjörn Kronander, President and CEO Sectra AB E-mail: [email protected] Phone: +46 705 23 5227 SOURCE Sectra, Inc Related Links http://www.sectra.com …
Nicolas Cacciabeve
… 17, 2020– As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic … including Zoltan Laszik, MD, PhD, Professor of Clinical Pathology, UCSF; Nicolas Cacciabeve, MD, Managing Partner, Advanced Pathology Associates; Kiran Motaparthi, MD, Program Director, Department of Dermatology, UF; and Anthony Magliocco, MD, President and CEO, Protean …
Robert Michel
AUSTIN, Texas–(BUSINESS WIRE)–Mar 17, 2020– As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling labs to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains. Compelled by recent technological advancements and regulatory approvals, academic and commercial laboratories …
Keith J. Kaplan
Roche and Illumina partner to broaden patient access to genomic testing | 1/14/2020
Roche and Illumina partner to broaden patient access to genomic testing BY Dr. Keith J. Kaplan Business , Clinical Laboratories , Data Management , Device Manufacturers , Digital Pathology News , Image Analysis , Laboratory Management & Operations , Molecular Pathology , New Digital Imaging Technologies , Pathology News , Vendor products Partnership to leverage Illumina’s extensive decentralised installed base with Roche’s expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves …
Michael Johnson
Visikol Expands Headquarters in Move to Hampton, NJ | PRWeb | 1/9/2020
… has been rapidly growing its business ever since. Today, Visikol has almost five dozen pharmaceutical companies that are leveraging its digital pathology, advanced imaging and 3D cell culture assays to accelerate their drug discovery and … services at an attractive price point,” described Visikol CEO Dr. Michael Johnson. Over the next few years, Visikol will use this new facility as a springboard to expand its services through continual R&D as …
Michael Johns
Visikol Expands Headquarters in Move to Hampton, NJ | PRWeb | 1/9/2020
… has been rapidly growing its business ever since. Today, Visikol has almost five dozen pharmaceutical companies that are leveraging its digital pathology, advanced imaging and 3D cell culture assays to accelerate their drug discovery and … services at an attractive price point,” described Visikol CEO Dr. Michael Johnson. Over the next few years, Visikol will use this new facility as a springboard to expand its services through continual R&D as …
Colin White
Sectra and Leica Biosystems Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology Solution News provided by Sectra, Inc Dec 02, 2019, 11:00 ET SHELTON, Connecticut , Dec. 2, 2019 /PRNewswire/ – International medical imaging … important step towards improving patient care with digital technology,” says Colin White , Global Vice President of Leica Biosystems Advanced Staining & Imaging Business. “We look forward to working with Sectra to offer streamlined digital pathology solutions …
David West
Proscia , a leading provider of digital pathology software, has been named to the CNBC Upstart 100, an exclusive list of venture-backed startups that have the potential to transform industries and become tomorrow’s household names … promise we bring to improving cancer research and diagnosis,” said David West, CEO. “The $30 billion pathology industry is on the verge of a massive shift to an AI-enabled computational approach, marking its first …
Andy Beck
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
… PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new … information to more effectively guide treatments for patients,” said CEO Andy Beck, M.D., Ph.D., when PathAI closed its $11 million A round two years ago. The latest investment deepens PathAI’s relationship with Merck and BMS …
Saurabh Saha
Merck, BMS chip in to PathAI’s series B, bringing total to $75M | FierceBiotech | 11/6/2019
… PathAI is at it again. Bristol-Myers Squibb and Merck’s Global Health Innovation Fund is adding $15 million to the digital pathology player’s series B, funding that will ramp up its R&D into new … we’ve seen the quality of PathAI’s work first-hand,” said Saurabh Saha, M.D., Ph.D., who leads the translational medicine unit at Bristol-Myers Squibb. “We are excited to take this next step in our partnership …
Pat Coll
Proscia’s Concentriq® Dx Receives CE Mark for Primary Diagnosis | PRWeb | 11/6/2019
Proscia’s Concentriq® Dx Receives CE Mark for Primary Diagnosis Share Article CE Mark enables Proscia’s entry into international anatomic pathology market PHILADELPHIA Proscia ®, a leading provider of digital pathology software, has received a CE Mark for its Concentriq Dx solution for use in primary diagnosis. With this certification, Proscia accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with …
Sarah Smith
… and Above-42-inch Panels), Resolution (Up to 2 MP, 2.1-4 MP, 4.1-8 MP, and Above 8 MP), and Application (Digital Pathology, Multi-modality, Surgical, Radiology, Mammography, and Other Applications): Global Opportunity Analysis and Industry … all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com View original content:https://www.prnewswire.com/news-releases/the-global …
Laura Wood
DUBLIN The “Digital Pathology: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. The implementation of cloud technology in healthcare has revolutionized healthcare systems. Also, the need for the transformation in healthcare delivery … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …
Kyle Blankenship
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Kyle Blankenship , and we will feature it here at the end of each week. After … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
Christi Shaw
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… become executive chair in September. FierceBiotech Lilly Bio-Medicines chief steps aside, leaving key launches behind Eli Lilly & Co. Chief Christi Shaw will exit her role at the end of August. Early into the Big … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
Richard Peters
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… feature it here at the end of each week. After exiting Merrimack, former CEO becomes new chief at Yumanity Yumanity Richard Peters was named CEO of the Fierce 15 winner. Troubled Merrimack Pharmaceuticals had recruited … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
Richard Scheller
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… retire at the end of the year. FiercePharma 23andMe therapeutics leader leaves for board roles at up-and-comers 23andMe Richard Scheller , Ph.D., has left his role as chief scientific officer. 23andMe’s former therapeutics foreman … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
Kenneth Hill
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… February. Scheller will continue on as a board member of 23andMe as well, where he helped recruit former Achaogen CEO Kenneth Hillan to take over as therapeutics head while Scheller remained CSO. FierceMedTech The U.S … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
Tony Coles
Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity | FierceBiotech | 7/12/2019
… C-suiters. Now, he looks to Yumanity for a more positive career move as he takes the reins from founder Tony Coles , who will become executive chair in September. FierceBiotech Lilly Bio-Medicines chief steps … Johnson & Johnson Innovation’s West Coast JLABS work. Release AI-driven digital pathology company Deep Lens hired Kevin Whiteley as VP of provider sales. Whiteley joins from Leica Biosystems, where he was VP of market and …
State of Connecticut
Mayo Clinic launches imaging solution to enable digital pathology across the enterprise | 6/26/2020
LINKÖPING, Sweden and SHELTON, Connecticut, June 25, 2020 /PRNewswire/ – In support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology. “As Mayo Clinic continues to lead the transformation of health care delivery and accessibility, the laboratories and …
Mayo Clinic launches imaging solution to enable digital pathology across the enterprise | 6/26/2020
LINKÖPING, Sweden and SHELTON, Connecticut, June 25, 2020 /PRNewswire/ – In support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digital pathology. “As Mayo Clinic continues to lead the transformation of health care delivery and accessibility, the laboratories and …
About:
Editor:
